Search Results
Aug 13, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
treatment of Duchenne muscular dystrophy. In July 2025, the FDA issued a Complete Response Letter because it could not approve the BLA in its current form. According to the Company, the CRL cited "that the BLA does not meet the statutory requirement for substantial evidence of effectiveness and the need
More news about: Pomerantz LLP
Aug 13, 2026, 10:00 ET WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
expectations include, among others, the Company's ability to close the offering when anticipated, and other factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. Such
More news about: WallachBeth Capital LLC
Aug 13, 2026, 10:00 ET Lupus Foundation of America Awards Grants to Early Career Scientists Advancing Understanding of Lupus and Targeted Treatment Pathways
cells to better understand how lupus occurs. Dr. Gu's study aims to understand how certain B cells develop and differentiate, and why autoantibodies form, to understand how lupus occurs and pave the way for more targeted treatments that improve symptoms for people living with lupus.Emma Materne,
More news about: Lupus Foundation of America, Inc.
Aug 13, 2026, 09:36 ET BLUETTI Debuts SORA 500 Portable Solar Panel in the U.S. for Peak RV Season
and portable power stations, while the portable form factor lets users position the panel for stronger sunlight as shade, angle, temperature, cable compatibility, and connected-device input limits allow.In
More news about: BLUETTI
Aug 13, 2026, 09:30 ET NeuroSense Issues CEO Letter to Shareholders
future. More information about the risks and uncertainties affecting NeuroSense is contained under the heading "Risk Factors" in the Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 31, 2026 and NeuroSense's subsequent filings with the SEC. Forward-looking statements
More news about: NeuroSense
Aug 13, 2026, 09:23 ET SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026
statements and in the section captioned "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on April 28, 2026, our reports on Form 6-K filed from time to time with the SEC and our other filings with the SEC.
More news about: SuperCom
Aug 13, 2026, 09:10 ET IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
instability in the Middle East, specifically in Israel; as well as those factors set forth in the Risk Factors section of the Company's Annual Report on Form 20-F for the year ended December 31, 2025 filed with the SEC on March 17, 2026, and other documents filed with or furnished to the SEC which are available
More news about: IceCure Medical
Aug 13, 2026, 09:10 ET Nucor to Invest $59 Million to Expand Production Capabilities at its Vulcraft Indiana Manufacturing Facility
regulatory filings with the United States Securities and Exchange Commission, including those in "Item 1A. Risk Factors" of Nucor's Annual Report on Form 10-K for the year ended December 31, 2025. The forward-looking statements contained in this news release speak only as of this date, and Nucor does
More news about: Nucor Corporation
Aug 13, 2026, 09:00 ET Built for Florida First Responders: Public Safety Agencies Across the State Modernize Public Safety Operations with Mark43
federal agencies faster, smarter, and their communities safer. Its integrated Records Management System, Computer-Aided Dispatch, and Data Analytics form the backbone of a unified, real-time public safety operating platform to streamline workflows, improve response times, and foster collaboration. Trusted
More news about: Mark43
Aug 13, 2026, 09:00 ET Intermountain Health Brings Perimeter's Claire™ to the Operating Room, a Landmark in Breast Cancer Surgery Using AI
such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events
More news about: Perimeter Medical Imaging AI Inc.
Aug 13, 2026, 09:00 ET PepsiCo Reports on Latest ESG Performance Towards pep+ Goals
materially from our expectations, please see PepsiCo's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Investors are cautioned not to place undue reliance on any such forward-looking statements, which
More news about: PepsiCo, Inc.
Aug 13, 2026, 09:00 ET Lifeway Foods® Delivers Highest Quarterly Net Sales in Company History, Extending Record Growth in Second Quarter 2026
of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Copies of these filings are available online at
More news about: Lifeway Foods, Inc.
Aug 13, 2026, 08:53 ET BOA Acquisition Corp. II Announces the Separate Trading of Its Class A Ordinary Shares and Rights, Commencing on August 14, 2026
[email protected], or by telephone at (212) 970-5150.The registration statement on Form S-1, as amended (File No. 333-290732), relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the "SEC")
More news about: BOA Acquisition Corp. II
Aug 13, 2026, 08:31 ET LiveU and Panasonic LUMIX Collaborate on Powerful "Live Anywhere" Production Workflow
directly from the crowded NAB 2026 and InfoComm 2026 show floors. The blend of mobile journalistic and IRL streaming styles provided engaging short form content for viewers who couldn't attend.
More news about: LiveU
Aug 13, 2026, 08:30 ET Former Japan National Team Player Yoichiro Kakitani Appointed Official Ambassador of "SIX SHOOT PREMIERE 0," Personally Coaching the Next Generation of Strikers at Official "BLUELOCK" Collaboration Tournament
but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC"). Although the Company believes that the expectations expressed in these forward-looking
More news about: LEIFRAS Co., Ltd.
Aug 13, 2026, 08:15 ET Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as may be supplemented or amended by the Company's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any intention or obligation to revise any forward-looking statements,
More news about: Pulmatrix Inc.
Aug 13, 2026, 08:15 ET Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
could differ materially from current projections or implied results. Investors should read the risk factors outlined in the Company's annual report on Form 10-K for the year ended December 31, 2025, on file with the Securities and Exchange Commission (the "SEC") and in previous filings, subsequent filings
More news about: Healthcare Triangle, Inc.
Aug 13, 2026, 08:10 ET Doctor Octopus Is Becoming Real: The Rise of Soft Embodied Intelligence
Designing beyond the humanoid formThe robot body is becoming the most overlooked variable in embodied intelligence.Humanoid robotics has drawn enormous capital on a simple
More news about: Feagine Robotics
Aug 13, 2026, 08:05 ET Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
result in the expected benefits. Additional risks and uncertainties are described in the "Risk Factors" section of Rigel's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 and in other filings Rigel makes with the Securities and Exchange Commission. Any forward-looking statement
More news about: Rigel Pharmaceuticals, Inc.
Aug 13, 2026, 08:03 ET Disrupting Venture Capital: Why AI Killed Proprietary Tech as a Moat
outdated perspective. Murtza sees a generational gap between the investors making decisions and the founders operating in a world shaped by for short-form content, micro-influencers, creator-led distribution, and conversion-driven attention. "There needs to be more younger people involved and more decision-making
More news about: Disruption Interruption
Aug 13, 2026, 08:01 ET NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40%
13761874The financial information included in this press release should be read in conjunction with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, to be filed with the Securities and Exchange Commission. About NextPlat CorpNextPlat
More news about: NextPlat Corp.
Aug 13, 2026, 08:00 ET AAON Announces Quarterly Cash Dividend
"Risk Factors" and "Forward Looking Statements" in AAON's Annual Report on Form 10-K for the most recent fiscal year, as may be revised and updated by AAON's Quarterly Reports on Form 10-Q, and AAON's Current Reports on Form 8-K.Contact InformationJoseph MondilloDirector
More news about: AAON
Aug 13, 2026, 08:00 ET CleanCore Solutions, Inc. (NYSE American: ZONE) Shareholder Update: Recently Announced Landmark $100 Million Public Equity Raise Advances its Minnesota AI Data Center Campus
please refer to the Company's filings with the SEC, including the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information,
More news about: CleanCore Solutions (NYSE AMERICAN: ZONE)
Aug 13, 2026, 08:00 ET Curis, Inc. Announces Pricing of $5.6 Million Public Offering
as co-placement agent in connection with the Offering.The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-298203) filed on August 10, 2026 and declared effective by the Securities and Exchange Commission (the "SEC") on August 12, 2026.
More news about: Curis, Inc.
Aug 13, 2026, 08:00 ET Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
Item 1A, "Risk Factors," in Lucid Diagnostics' most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as the same may be updated in Part II, Item 1A, "Risk Factors" in any Quarterly Report on Form 10-Q filed by Lucid Diagnostics after its most recent Annual Report. Lucid
More news about: Lucid Diagnostics